MedTrace Logo

Screening and Understanding of the Pre-diabetes: DECODIAB

NCT01739868 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 103

Last updated 2015-04-16

No results posted yet for this study

Summary

The main objective of the study is to understand the pathophysiological mechanisms involved in switching from pre-diabetes to type 2 diabetes and to identify new biomarkers of type 2 diabetes risk in the population of patients with pre-diabetes.

Conditions

  • Pre-diabetes

Interventions

OTHER

Biopsies of muscular and fat tissue

3 half days of metabolic exploration including blood sample, urinary taking, OGTT (oral glucose tolerance test), biopsies of muscular and fat tissue: * 1 visit the first year (inclusion visit) * 1 visit at the end of 5 years of follow-up or in the appearance of type 2 diabetes * 1 intermediary visit (in 3 years) or activated by the following conditions: * Escalation of the glycemia (increase of 0.1g / l of the glycemia and/or 0.3 % of the HbA1c) * Normalization of the glycemia (fasting blood glucose \< 1 g/l)

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Principal Investigators

  • Bertrand CARIOU, Pr · Nantes University Hospital

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2018-04-30
Completion
2018-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01739868 on ClinicalTrials.gov